HomeCompareVIHAX vs CL

VIHAX vs CL: Dividend Comparison 2026

VIHAX yields 3.62% · CL yields 2.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CL wins by $15.7K in total portfolio value· pulled ahead in Year 3
10 years
VIHAX
VIHAX
● Live price
3.62%
Share price
$45.54
Annual div
$1.65
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$457.42
Full VIHAX calculator →
CL
CL
● Live price
2.44%
Share price
$85.23
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.0K
Annual income
$5,451.69
Full CL calculator →

Portfolio growth — VIHAX vs CL

📍 CL pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVIHAXCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VIHAX + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VIHAX pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VIHAX
Annual income on $10K today (after 15% tax)
$308.01/yr
After 10yr DRIP, annual income (after tax)
$388.81/yr
CL
Annual income on $10K today (after 15% tax)
$207.44/yr
After 10yr DRIP, annual income (after tax)
$4,633.94/yr
At 15% tax rate, CL beats the other by $4,245.13/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VIHAX + CL for your $10,000?

VIHAX: 50%CL: 50%
100% CL50/50100% VIHAX
Portfolio after 10yr
$33.1K
Annual income
$2,954.56/yr
Blended yield
8.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

VIHAX
No analyst data
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+8.5% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VIHAX buys
0
CL buys
0
No recent congressional trades found for VIHAX or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVIHAXCL
Forward yield3.62%2.44%
Annual dividend / share$1.65$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$25.3K$41.0K
Annual income after 10y$457.42$5,451.69
Total dividends collected$4.1K$18.1K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: VIHAX vs CL ($10,000, DRIP)

YearVIHAX PortfolioVIHAX Income/yrCL PortfolioCL Income/yrGap
1$11,062$362.36$11,014$313.84+$48.00VIHAX
2$12,211$374.63$12,200$415.44+$11.00VIHAX
3← crossover$13,453$386.49$13,607$553.09$154.00CL
4$14,792$397.92$15,301$741.41$509.00CL
5$16,237$408.92$17,374$1,002.00$1.1KCL
6$17,793$419.49$19,958$1,367.44$2.2KCL
7$19,468$429.62$23,243$1,887.87$3.8KCL
8$21,270$439.31$27,512$2,642.43$6.2KCL
9$23,207$448.58$33,197$3,759.22$10.0KCL
10$25,289$457.42$40,973$5,451.69$15.7KCL

VIHAX vs CL: Complete Analysis 2026

VIHAXStock

This fund offers investors a low cost way to gain exposure to international companies that are forecasted to have higher-than-average dividend yields. The fund seeks to track a market cap weighted benchmark of stocks in both developed and emerging economies outside the United States. Because it invests in non-U.S. stocks, the fund can be more volatile than a domestic fund. The fund’s emphasis on slower-growing, higher-yielding companies can also mean that its total return may not be as strong in a significant bull market. This income-focused fund may be appropriate for investors who have a long-term investment goal and a tolerance for stock market volatility.

Full VIHAX Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this VIHAX vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VIHAX vs SCHDVIHAX vs JEPIVIHAX vs OVIHAX vs KOVIHAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.